Your session is about to expire
← Back to Search
Corneal Collagen Crosslinking for Corneal Ulcer
Study Summary
This trial is being done to see if the PXL Platinum 330 System is safe and effective for performing corneal collagen crosslinking for the treatment of refractory corneal ulcers.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I agree to have a corneal culture for an eye infection.I have an eye infection, but it's not in the center of the cornea or causing pus in the eye.I have a hole in my cornea due to an ulcer.I am 18 years old or older.I have had an eye condition that could cause future problems.I do not have an uncontrolled systemic disease affecting my cornea.I have a severe ulcer in my eye.My eye infection hasn't improved with standard antibiotic drops.I have a deep corneal ulcer.I am suspected to have an eye infection needing special eye drops.
- Group 1: Standard of care + Sham CXL + Artificial Tears
- Group 2: Standard of care + CXL + Riboflavin 0.25% TE Solution
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
At how many different hospitals is this research study being conducted?
"This trial has sites in Indianapolis, Indiana; Littleton, Colorado; Columbia, South carolina; and 12 other locations."
Are people still being accepted into the program?
"The trial is actively recruiting patients, as can be seen from the information available on clinicaltrials.gov. The trial was posted on 3/14/2022 and was most recently edited on 10/26/2022. They are looking for 488 patients at 12 locations."
What is the cut-off for how many people can join this test group?
"Yes, this is an active clinical trial that is recruiting 488 participants from 12 sites. The first posting was on 3/14/2022, with the most recent update on 10/26/2022."
Share this study with friends
Copy Link
Messenger